The Federal Reserve held rates at 3.75% to 4% on a 10-2 vote, with Lisa Cook and Beth Hammack wanting a hike. Chairman Kevin Warsh then said one 2027 meeting will carry
Ask 10 individuals why they started investing in mutual funds, and you will probably hear ten different stories. Some people tried to beat inflation; others simply got tired of earning little money from savings accounts. Even if their answers differ,
PHOENIX, Oct. 29, 2026 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) (“we,” “our,” the “Company” or “Cavco”) today announced financial results for the second fiscal quarter ended September 26, 2026. Quarterly
BEVERLY HILLS, California, Oct. 29, 2026 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a biotech company specializing in developing breakthrough therapeutics in diseases with unmet medical needs,
KALISPELL, Mont., Oct. 29, 2026 (GLOBE NEWSWIRE) — Glacier Bancorp, Inc. (the “Company”) (NYSE: GBCI) announced today that its Board of Directors approved a new stock repurchase program authorizing the Company to
SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) — Medallion Bank (Nasdaq: MBNKO, the “Bank”), an FDIC-insured bank providing consumer loans for the purchase of recreational vehicles, boats, and home improvements, along
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year. Combined revenues of the Company’s four growth products increased to $192.2 million
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to
Diluted earnings per share (“EPS”) of $0.95 Invested $84 million in water and wastewater utility infrastructure during the nine months ended September 30, 2026 Declared $0.38 common stock cash dividend, a 5.56%
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today announced two presentations
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) — Aspen Neuroscience, Inc. (Nasdaq: ASPE), a clinical-stage regenerative medicine biotechnology company developing autologous cell therapies for Parkinson’s disease (PD), today announced the pricing of
SARATOGA, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) — CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release
Follow